Difference between revisions of "Naftidrofuryl"

Jump to: navigation, search
m (Robot: Automated text replacement (-(?ms)^(.*)$ +\1 {{WikiDoc Sources}}))
Line 24: Line 24:
 
| routes_of_administration =  
 
| routes_of_administration =  
 
}}
 
}}
 +
 +
{{CMG}}{{AE}}{{SS}}
 +
 
'''Naftidrofuryl''' ([[International Nonproprietary Name|INN]], also known as '''nafronyl''' or as the [[oxalate]] salt '''nafronyl oxalate''') is a drug used in the management of peripheral and [[cerebral]] [[Blood vessel|vascular]] disorders. It is claimed to enhance cellular oxidative capacity and to be a [[spasmolytic]].<ref>{{cite book |author=Reynolds, J.E.F. (ed.)|title=[[Martindale: The complete drug reference|Martindale: The extra pharmacopoeia]] |publisher=Pharmaceutical Press |location=London |year=1993 |edition=30th edition |pages=p. 1310 |isbn=0853693005}}</ref> It may also be a  [[5-HT receptor|5-HT<sub>2</sub> receptor]] [[receptor antagonist|antagonist]].
 
'''Naftidrofuryl''' ([[International Nonproprietary Name|INN]], also known as '''nafronyl''' or as the [[oxalate]] salt '''nafronyl oxalate''') is a drug used in the management of peripheral and [[cerebral]] [[Blood vessel|vascular]] disorders. It is claimed to enhance cellular oxidative capacity and to be a [[spasmolytic]].<ref>{{cite book |author=Reynolds, J.E.F. (ed.)|title=[[Martindale: The complete drug reference|Martindale: The extra pharmacopoeia]] |publisher=Pharmaceutical Press |location=London |year=1993 |edition=30th edition |pages=p. 1310 |isbn=0853693005}}</ref> It may also be a  [[5-HT receptor|5-HT<sub>2</sub> receptor]] [[receptor antagonist|antagonist]].
  
 
==References==
 
==References==
{{Reflist}}
+
{{Reflist|2}}
  
 
[[Category:Vasodilators]]
 
[[Category:Vasodilators]]
 
+
[[Category:Naphthalenes]]
 +
[[Category:Tetrahydrofurans]]
 +
[[Category:Carboxylate esters]]
 +
[[Category:Amines]]
 +
[[Category:Cardiovascular Drugs]][[Category:Drugs]]
  
 
{{pharma-stub}}
 
{{pharma-stub}}
 
{{Peripheral vasodilators}}
 
{{Peripheral vasodilators}}
 
{{WikiDoc Sources}}
 
{{WikiDoc Sources}}

Revision as of 18:58, 24 July 2014

Naftidrofuryl
File:Naftidrofuryl.svg
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC24H33NO3
Molar mass383.524 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Naftidrofuryl (INN, also known as nafronyl or as the oxalate salt nafronyl oxalate) is a drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic.[1] It may also be a 5-HT2 receptor antagonist.

References

  1. Reynolds, J.E.F. (ed.) (1993). Martindale: The extra pharmacopoeia (30th edition ed.). London: Pharmaceutical Press. pp. p. 1310. ISBN 0853693005.



Linked-in.jpg